The 36-month beta value for OPK is at 1.39. Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 4 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for OPK is 350.22M, and currently, shorts hold a 9.72% of that float. The average trading volume for OPK on June 03, 2025 was 4.93M shares.
OPK) stock’s latest price update
The stock of Opko Health Inc (NASDAQ: OPK) has increased by 1.47 when compared to last closing price of 1.36.Despite this, the company has seen a gain of 9.52% in its stock price over the last five trading days. globenewswire.com reported 2025-05-15 that MIAMI, May 15, 2025 (GLOBE NEWSWIRE) — OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in two investor conferences over the coming weeks. H.C. Wainwright 3 rd Annual BioConnect Investor Conference at Nasdaq, May 20 in New York City.
OPK’s Market Performance
OPK’s stock has risen by 9.52% in the past week, with a monthly rise of 2.22% and a quarterly drop of -21.14%. The volatility ratio for the week is 2.33% while the volatility levels for the last 30 days are 2.81% for Opko Health Inc The simple moving average for the last 20 days is 5.87% for OPK’s stock, with a simple moving average of -10.44% for the last 200 days.
Analysts’ Opinion of OPK
Barrington Research, on the other hand, stated in their research note that they expect to see OPK reach a price target of $2. The rating they have provided for OPK stocks is “Outperform” according to the report published on June 29th, 2023.
H.C. Wainwright gave a rating of “Buy” to OPK, setting the target price at $3 in the report published on December 15th of the previous year.
OPK Trading at -3.90% from the 50-Day Moving Average
After a stumble in the market that brought OPK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -32.19% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OPK starting from FROST PHILLIP MD ET AL, who purchase 125,000 shares at the price of $1.36 back on Apr 10 ’25. After this action, FROST PHILLIP MD ET AL now owns 214,001,448 shares of Opko Health Inc, valued at $169,712 using the latest closing price.
FROST PHILLIP MD ET AL, the CEO & Chairman of Opko Health Inc, purchase 125,000 shares at $1.48 during a trade that took place back on Apr 08 ’25, which means that FROST PHILLIP MD ET AL is holding 213,876,448 shares at $184,650 based on the most recent closing price.
Stock Fundamentals for OPK
Current profitability levels for the company are sitting at:
- -0.21 for the present operating margin
- 0.32 for the gross margin
The net margin for Opko Health Inc stands at -0.06. The total capital return value is set at -0.08. Equity return is now at value -3.04, with -1.90 for asset returns.
Based on Opko Health Inc (OPK), the company’s capital structure generated 0.27 points at debt to capital in total, while cash flow to debt ratio is standing at -0.37. The debt to equity ratio resting at 0.38. The interest coverage ratio of the stock is -2.67.
Currently, EBITDA for the company is 135.28 million with net debt to EBITDA at 0.48. When we switch over and look at the enterprise to sales, we see a ratio of 1.67. The receivables turnover for the company is 7.17for trailing twelve months and the total asset turnover is 0.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.49.
Conclusion
In conclusion, Opko Health Inc (OPK) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
